Antiviral drug resistance
- 1 September 2006
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 71 (2-3) , 117-121
- https://doi.org/10.1016/j.antiviral.2006.03.004
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Avian Influenza A (H5N1) Infection in HumansNew England Journal of Medicine, 2005
- Genetic Composition of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid and Blood without Treatment and during Failing Antiretroviral TherapyJournal of Virology, 2005
- Semen-Specific Genetic Characteristics of Human Immunodeficiency Virus Type 1 envJournal of Virology, 2005
- Broad Nucleoside Reverse‐Transcriptase Inhibitor Cross‐Resistance in Human Immunodeficiency Virus Type 1 Clinical IsolatesThe Journal of Infectious Diseases, 2003
- Structured Treatment Interruption in Patients with Multidrug-Resistant Human Immunodeficiency VirusNew England Journal of Medicine, 2003
- A novel TaqMan real-time PCR assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapyJournal of General Virology, 2003
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- Influenza virus M2 protein has ion channel activityPublished by Elsevier ,1992
- In vivo Selection of an Influenza A2 Strain resistant to AmantadineNature, 1970
- COMBINED DRUG TREATMENT OF TUBERCULOSIS. I. PREVENTION OF EMERGENCE OF MUTANT POPULATIONS OF TUBERCLE BACILLI RESISTANT TO BOTH STREPTOMYCIN AND ISONIAZID IN VITROJournal of Clinical Investigation, 1959